VESIcare: profile and news

Astellas Pharma Obtains Approval for Funguard and Vesicare  Apr 21, 2006
...obtained additional approval for Funguard for Infusion 50mg/75mg, its proprietary candin antifungal agents, and manufacturing approval for Vesicare Tablet, its ... - Japan Corporate News (press release),

Astellas 05/06 profit up 4 pct, sees decline  May 15, 2006
Strong sales of Micardis hypertension treatment and incontinence drug Vesicare offset higher spending in research and development, including fees to acquire ... - Reuters

EAU 2006: SUNRISE* Study Backgrounder  Apr 18, 2006
Solifenacin patients accepting this offer were randomised to receive either 10 mg Vesicare@ or to remain on 5 mg Vesicare® plus placebo for a second eight ... - UroToday,

DTC National Advertising Awards Winners  Apr 27, 2006
Astellas/GlaxoSmithKline won the Silver Award for its integrated VESIcare campaign, a collaboration with agencies Euro RSCG Tonic, One to One Interactive ... - DTC Perspectives Magazine,

EAU 2006: Major New Study Confirms Solifenacin Effectively Treats ...  Apr 18, 2006
New data presented today at the European Association of Urology Congress confirm that solifenacin (Vesicare®) provides fast, effective treatment of urgency ... - UroToday,

Drug maker phasing out product made at GI plant  Apr 17, 2006
Astellas also operates a plant in Norman, Okla., that makes Vesicare, a brand-name medication used to treat an overactive bladder condition. ... - MSNBC